Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the reconciliation of the numerator and denominator of basic and diluted loss per share:


	Twelve Months Ended December 31, 2021		Twelve Months Ended December 31, 2020
	(dollars in thousands, except per share data)
Numerator:
Net (loss)	$	(6,963)	$	(5,710)
Denominator:
Weighted average shares outstanding, basic	10,320		9,779
Dilutive effect of stock-based awards	—		—
Weighted average shares outstanding, diluted	10,320		9,779

Basic loss per share	$	(0.67)	$	(0.58)
Diluted loss per share	$	(0.67)	$	(0.58)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

A summary of these anti-dilutive common stock equivalents is provided in the table below:


	Twelve Months Ended December 31, 2021		Twelve Months Ended December 31, 2020
Number of options	846,731		726,500
Exercise price of options	$2.08 - $12.58		$2.36 - $12.58
Warrants (1)	156,320		—
Exercise price of warrants	$	3.12	—

________________________________

(1)Includes warrants to purchase 156,320 shares of common stock issued to the underwriters of the Company’s equity issuance in September 2021 with an exercise price of $3.12 per share of common stock, which expire on September 21, 2026.